Your browser doesn't support javascript.
loading
The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas.
Bisaccia, Joseph; Meyer, Swann; Bertrand-Chapel, Adrien; Hecquet, Quentin; Barbet, Virginie; Kaniewski, Bastien; Léon, Sophie; Gadot, Nicolas; Rochet, Isabelle; Fajnorova, Iveta; Leblond, Pierre; Cordier-Bussat, Martine; Corradini, Nadège; Vasiljevic, Alexandre; Billaud, Marc; Picard, Cécile; Broutier, Laura; Gallerne, Cindy; Dutour, Aurélie; Blay, Jean-Yves; Castets, Marie.
Affiliation
  • Bisaccia J; Cell Death and Childhood Cancers Laboratory, LabEx DEV2CAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052- CNRS UMR5286, Université Claude Bernard de Lyon, Centre Léon Bérard, Institut Convergence Plascan, Lyon, France.
  • Meyer S; Cell Death and Childhood Cancers Laboratory, LabEx DEV2CAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052- CNRS UMR5286, Université Claude Bernard de Lyon, Centre Léon Bérard, Institut Convergence Plascan, Lyon, France.
  • Bertrand-Chapel A; Cell Death and Childhood Cancers Laboratory, LabEx DEV2CAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052- CNRS UMR5286, Université Claude Bernard de Lyon, Centre Léon Bérard, Institut Convergence Plascan, Lyon, France.
  • Hecquet Q; Cell Death and Childhood Cancers Laboratory, LabEx DEV2CAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052- CNRS UMR5286, Université Claude Bernard de Lyon, Centre Léon Bérard, Institut Convergence Plascan, Lyon, France.
  • Barbet V; Cell Death and Childhood Cancers Laboratory, LabEx DEV2CAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052- CNRS UMR5286, Université Claude Bernard de Lyon, Centre Léon Bérard, Institut Convergence Plascan, Lyon, France.
  • Kaniewski B; Cell Death and Childhood Cancers Laboratory, LabEx DEV2CAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052- CNRS UMR5286, Université Claude Bernard de Lyon, Centre Léon Bérard, Institut Convergence Plascan, Lyon, France.
  • Léon S; EX-VIVO Platform, Université de Lyon, Université Claude Bernard de Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon (CRCL), Lyon, France.
  • Gadot N; Anatomopathology Research Platform, Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Rochet I; Department of Pathology, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, Université de Lyon, Lyon, France.
  • Fajnorova I; Cell Death and Childhood Cancers Laboratory, LabEx DEV2CAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052- CNRS UMR5286, Université Claude Bernard de Lyon, Centre Léon Bérard, Institut Convergence Plascan, Lyon, France.
  • Leblond P; Cell Death and Childhood Cancers Laboratory, LabEx DEV2CAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052- CNRS UMR5286, Université Claude Bernard de Lyon, Centre Léon Bérard, Institut Convergence Plascan, Lyon, France.
  • Cordier-Bussat M; Department of Pediatric Oncology, Institut d'hématologie et d'oncologie pédiatrique, Centre Léon Bérard, Lyon, France.
  • Corradini N; Department of Translational Research in Paediatric Oncology, Centre Léon Bérard, Lyon, France.
  • Vasiljevic A; Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France.
  • Billaud M; Cell Death and Childhood Cancers Laboratory, LabEx DEV2CAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052- CNRS UMR5286, Université Claude Bernard de Lyon, Centre Léon Bérard, Institut Convergence Plascan, Lyon, France.
  • Picard C; Department of Translational Research in Paediatric Oncology, Centre Léon Bérard, Lyon, France.
  • Broutier L; Cell Death and Childhood Cancers Laboratory, LabEx DEV2CAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052- CNRS UMR5286, Université Claude Bernard de Lyon, Centre Léon Bérard, Institut Convergence Plascan, Lyon, France.
  • Gallerne C; Department of Pediatric Oncology, Institut d'hématologie et d'oncologie pédiatrique, Centre Léon Bérard, Lyon, France.
  • Dutour A; Department of Translational Research in Paediatric Oncology, Centre Léon Bérard, Lyon, France.
  • Blay JY; Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France.
  • Castets M; Department of Pathology, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, Université de Lyon, Lyon, France.
Cell Death Discov ; 9(1): 230, 2023 Jul 07.
Article in En | MEDLINE | ID: mdl-37414800
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cell Death Discov Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cell Death Discov Year: 2023 Document type: Article Affiliation country: Country of publication: